Shandong Lukang Pharmaceutical Co.,Ltd.

¥7.10As of Sun 8 Nov 2026, 12:00 UTC
SSE:600789Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (0.03%)
Div yield 0.70%
ROE 2.98%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.31
PE TTM 54.61
TSR TTM (28.65%)
Mkt cap ¥7.421B
ROIC 2.76%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥7.33
3.29%
(14.95%)
Hold 0|3|11|11|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.12
0.14
0.14
0.14
12.80%
22.82%
28.98%
19.77%
Revenue¥M
840.1
833.2
872.4
908.5
1.91%
(3.24%)
2.21%
6.04%
Peers (US$1.112B)
Cap (US$)
PE
1.122B
107.4x
1.094B
—
Capital
TTM
5Y
10Y
Leveragex
0.128
0.910
0.676
EBIT/Intx
1.044
0.087
0.088
Own earn%
208.31
131.41
96.52
Sh yield%
25.23
14.63
12.40
Owners
Insiders/Inst%
13.61
54.65
Short interest%
1.83
SBC / revenue%
5.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
6–12
$1 testx
0.3
Incr. ROIC%
8